Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Title Grant Type Focus Area Country Application Due Date 2021 Ulcerative Colitis Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Adoption of Biosimilars in OncologyRelease Date:Quality Improvement Oncology Canada 2021 Global Hemophilia ASPIRERelease Date:Research Rare Disease All Inflammatory and Immune-Mediated Dermatologic DisordersRelease Date:Research Inflammation & Immunology USA Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant LipoproteinsRelease Date:Education Internal Medicine All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World ExperienceRelease Date:Research Inflammation & Immunology Italy 2021 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)Release Date:Research Inflammation & Immunology All 2021 Rheumatology FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2021 Fellowship for Inflammatory Dermatological DiseasesRelease Date:Fellowship Inflammation & Immunology USA